Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Albendazole may cause hair loss.

Thyroid hormone treatments help thyroidectomized rats grow normally.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Stress turns hair white by depleting color-giving cells in hair follicles through a specific neurotransmitter related to the body's stress response.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

Tianeptine, an antidepressant, may prevent stress-induced hair loss in mice.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

The conclusion is that a systematic approach is key for treating symmetrical alopecia in dogs, but treatment may not always be necessary.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

Hair loss led to the diagnosis of Cushing's disease in a patient, showing that hair loss can be a sign of hormonal disorders.

Testosterone injections can cause skin darkening and thickening.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Finasteride causes temporary cell death in BPH tissues.

Topical corticosteroid was not more effective than placebo for children's alopecia areata, and atopy did not change treatment results.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Clascoterone may be a promising treatment for hair loss.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.